Newsquawk Logo

Ligand Pharmaceuticals (LGND) to acquire Xoma Royalty (XOMA) for c. USD 740mln, WSJ reports citing sources

Ligand Pharmaceuticals' acquisition of Xoma Royalty for approximately USD 740 million signals a strategic expansion into royalties that could enhance their revenue stream.

Newsquawk StaffPublished On the live feed at — 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Domino's Pizza (DPZ) Q1 2026 (USD): EPS 4.13 (exp. 4.27), Revenue 1.15bln (exp. 1.16bln); Q1 SSS +0.9% (exp. 2.6%); announces USD 1bln share buyback

The Real Brokerage (REAX) is to purchase Re/Max Holdings (RMAX), WSJ reports citing sources

Ligand Pharmaceuticals (LGND) to acquire Xoma Royalty (XOMA) for c. USD 740mln, WSJ reports citing sources

Medtronic (MDT) discloses it had unauthorised access to its systems, according to a filing

Canadian PM Carney is reportedly to announce a sovereign wealth fund, Globe and Mail reports; set to be announced on Monday, with the fund to invest alongside the private sector in major projects that the PM had promised to build

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This move may be viewed positively by investors if it is seen as financially prudent and strategically aligned, potentially boosting Ligand's position in the market while also reflecting confidence in future growth prospects.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.